Sign in or create an account to add this stock to your watchlist.
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease (ESRD). The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company operates DaVita Rx, a pharmacy that provides oral medications and medication management services to patients with ESRD; disease management services; vascular access services; clinical research programs; physician services; and direct primary care services. As of December 31, 2017, it provided dialysis and administrative services in the United States through a network of 2,510 outpatient dialysis centers serving approximately 197,800 patients; and operated 237 outpatient dialysis centers located in 11 countries outside of the United States. Further, the company provides acute inpatient dialysis services in approximately 900 hospitals and related laboratory services in the United States. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was founded in 1994 and is headquartered in Denver, Colorado.
Industry, Sector and Symbol
Industry Miscellaneous health & allied services, not elsewhere classified
Sub-IndustryHealth Care Services
Trailing P/E Ratio20.46
Forward P/E Ratio16.57
Sales & Book Value
Annual Sales$10.88 billion
Price / Sales1.09
Cash Flow$7.6833 per share
Price / Cash8.84
Book Value$26.66 per share
Price / Book2.55
EPS (Most Recent Fiscal Year)$3.32
Net Income$663.61 million
Return on Equity13.84%
Return on Assets3.61%
DaVita (NYSE:DVA) Frequently Asked Questions
What is DaVita's stock symbol?
DaVita trades on the New York Stock Exchange (NYSE) under the ticker symbol "DVA."
How will DaVita's stock buyback program work?
DaVita declared that its Board of Directors has initiated a share buyback plan on Wednesday, October 11th 2017, which authorizes the company to repurchase $1,500,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization authorizes the company to repurchase shares of its stock through open market purchases. Stock repurchase plans are generally a sign that the company's management believes its stock is undervalued.
How were DaVita's earnings last quarter?
DaVita (NYSE:DVA) posted its quarterly earnings results on Thursday, May, 3rd. The company reported $1.05 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $0.92 by $0.13. The company had revenue of $2.85 billion for the quarter, compared to analyst estimates of $2.79 billion. DaVita had a net margin of 2.94% and a return on equity of 13.84%. The business's quarterly revenue was up 8.3% compared to the same quarter last year. During the same period last year, the firm earned $0.79 earnings per share. View DaVita's Earnings History.
When is DaVita's next earnings date?
What price target have analysts set for DVA?
11 equities research analysts have issued twelve-month price objectives for DaVita's stock. Their forecasts range from $60.00 to $97.00. On average, they anticipate DaVita's stock price to reach $79.00 in the next year. View Analyst Ratings for DaVita.
Who are some of DaVita's key competitors?
Who are DaVita's key executives?
DaVita's management team includes the folowing people:
- Mr. Kent J. Thiry, Chairman & CEO (Age 62)
- Mr. James K. Hilger, Chief Accounting Officer (Age 56)
- Ms. Kathleen Alyce Waters, Chief Legal Officer (Age 50)
- Mr. Javier J. Rodriguez, Chief Exec. Officer of Kidney Care (Age 47)
- Ms. LeAnne M. Zumwalt, Group VP of Purchasing & Public Affairs (Age 59)
Has DaVita been receiving favorable news coverage?
News stories about DVA stock have been trending somewhat positive this week, according to Accern. The research group ranks the sentiment of media coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. DaVita earned a daily sentiment score of 0.13 on Accern's scale. They also gave news headlines about the company an impact score of 46.36 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock's share price in the next several days.
Who are DaVita's major shareholders?
DaVita's stock is owned by a variety of of retail and institutional investors. Top institutional investors include BlackRock Inc. (7.09%), Manning & Napier Group LLC (2.09%), Dimensional Fund Advisors LP (1.58%), OppenheimerFunds Inc. (1.47%), Northern Trust Corp (1.19%) and Neuberger Berman Group LLC (1.18%). Company insiders that own DaVita stock include Charles Berg, James K Hilger, Javier Rodriguez, Jeanine Marie Jiganti, Kent J Thiry, Leanne M Zumwalt, Michael David Staffieri, Pamela M Arway and William L Roper. View Institutional Ownership Trends for DaVita.
Which major investors are selling DaVita stock?
DVA stock was sold by a variety of institutional investors in the last quarter, including Park West Asset Management LLC, FIL Ltd, Neuberger Berman Group LLC, Manning & Napier Group LLC, DekaBank Deutsche Girozentrale, BlackRock Inc., Prudential Financial Inc. and Sei Investments Co.. Company insiders that have sold DaVita company stock in the last year include Charles Berg, James K Hilger, Javier Rodriguez, Kent J Thiry and Leanne M Zumwalt. View Insider Buying and Selling for DaVita.
Which major investors are buying DaVita stock?
DVA stock was purchased by a variety of institutional investors in the last quarter, including OppenheimerFunds Inc., Boston Partners, Wedge Capital Management L L P NC, Old Mutual Global Investors UK Ltd., Rock Springs Capital Management LP, Pendal Group Ltd, Mackay Shields LLC and Toronto Dominion Bank. View Insider Buying and Selling for DaVita.
How do I buy shares of DaVita?
Shares of DVA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is DaVita's stock price today?
One share of DVA stock can currently be purchased for approximately $67.92.
How big of a company is DaVita?
DaVita has a market capitalization of $11.89 billion and generates $10.88 billion in revenue each year. The company earns $663.61 million in net income (profit) each year or $3.32 on an earnings per share basis. DaVita employs 74,500 workers across the globe.
How can I contact DaVita?
DaVita's mailing address is 2000 16TH STREET, DENVER CO, 80202. The company can be reached via phone at 303-405-2100 or via email at [email protected]
MarketBeat Community Rating for DaVita (DVA)MarketBeat's community ratings are surveys of what our community members think about DaVita and other stocks. Vote "Outperform" if you believe DVA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe DVA will underperform the S&P 500 over the long term. You may vote once every thirty days.
DaVita (NYSE:DVA) Price Target and Consensus Rating (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
11 Wall Street analysts have issued ratings and price targets for DaVita in the last 12 months. Their average twelve-month price target is $79.00, suggesting that the stock has a possible upside of 16.31%. The high price target for DVA is $97.00 and the low price target for DVA is $60.00. There are currently 1 sell rating, 4 hold ratings, 4 buy ratings and 2 strong buy ratings for the stock, resulting in a consensus rating of "Buy."
|Today||30 Days Ago||90 Days Ago||180 Days Ago|
|Consensus Rating: ||Buy||Buy||Buy||Hold|
|Consensus Rating Score: ||2.64||2.64||2.64||1.89|
|Ratings Breakdown: ||1 Sell Rating(s)|
4 Hold Rating(s)
4 Buy Rating(s)
2 Strong Buy Rating(s)
|1 Sell Rating(s)|
4 Hold Rating(s)
4 Buy Rating(s)
2 Strong Buy Rating(s)
|1 Sell Rating(s)|
4 Hold Rating(s)
4 Buy Rating(s)
2 Strong Buy Rating(s)
|2 Sell Rating(s)|
6 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
|Consensus Price Target: ||$79.00||$79.00||$79.00||$63.00|
|Price Target Upside: ||16.31% upside||5.86% upside||5.86% upside||14.57% upside|
DaVita (NYSE:DVA) Consensus Price Target History
DaVita (NYSE:DVA) Analyst Ratings History
(Data available from 5/22/2016 forward)
DaVita (NYSE:DVA) Dividend History by Quarter
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
DaVita (NYSE DVA) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 0.95%
Institutional Ownership Percentage: 87.62%
DaVita (NYSE DVA) Insider Trading History
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
|5/14/2018||Charles Berg||Director||Sell||338||$66.25||$22,392.50||29,776|| |
|1/16/2018||James K Hilger||Insider||Sell||3,572||$78.95||$282,009.40||33,649|| |
|12/11/2017||Charles Berg||Insider||Sell||7,048||$69.24||$488,003.52||5,359|| |
|12/8/2017||Kent J Thiry||Chairman||Sell||81,800||$68.04||$5,565,672.00|| |
|12/8/2017||Leanne M Zumwalt||VP||Sell||949||$68.19||$64,712.31||12,423|| |
|12/7/2017||James K Hilger||Insider||Sell||5,608||$69.46||$389,531.68||47,649|| |
|12/7/2017||Javier Rodriguez||CEO||Sell||22,532||$67.48||$1,520,459.36||210,317|| |
|5/15/2017||Javier Rodriguez||CEO||Sell||1,294||$66.21||$85,675.74||99,111|| |
|5/9/2017||Charles Berg||Director||Sell||8,414||$65.80||$553,641.20||34,719|| |
|5/4/2017||William L Roper||Director||Sell||12,994||$65.89||$856,174.66||45,277|| |
|8/9/2016||Michael David Staffieri||COO||Sell||20,262||$73.09||$1,480,949.58||52,279|| |
|7/11/2016||Jeanine Marie Jiganti||Insider||Sell||1,291||$78.51||$101,356.41||5,716|| |
|7/1/2016||Jeanine Marie Jiganti||Insider||Sell||4,620||$77.45||$357,819.00||7,590|| |
|5/25/2016||Pamela M Arway||Director||Sell||10,824||$77.16||$835,179.84||36,394|| |
|5/23/2016||James K Hilger||CFO||Sell||3,416||$76.79||$262,314.64||29,147|| |
|5/20/2016||Kent J Thiry||CEO||Sell||32,880||$76.99||$2,531,431.20||39,184|| |
|5/17/2016||Dennis Kogod||CEO||Sell||17,700||$77.35||$1,369,095.00||18,766|| |
|5/17/2016||Leanne M Zumwalt||VP||Sell||538||$77.08||$41,469.04||8,585|| |
|5/16/2016||James K Hilger||CFO||Sell||3,983||$75.59||$301,074.97||21,130|| |
|5/16/2016||Javier Rodriguez||CEO||Sell||36,466||$75.44||$2,750,995.04||64,264|| |
|5/16/2016||Michael David Staffieri||COO||Sell||4,934||$75.69||$373,454.46||12,279|| |
|5/12/2016||Roger Valine||Director||Sell||8,220||$76.34||$627,514.80||18,324|| |
|5/10/2016||Dennis Kogod||CEO||Sell||40,048||$76.25||$3,053,660.00||92,716|| |
|5/6/2016||John M Nehra||Director||Sell||16,314||$75.56||$1,232,685.84||36,665|| |
|4/11/2016||Javier Rodriguez||CEO||Sell||89,912||$73.51||$6,609,431.12||317,397|| |
|3/21/2016||Dennis Kogod||CEO||Sell||13,455||$72.12||$970,374.60||92,716|| |
|2/29/2016||Pamela M Arway||Director||Sell||9,026||$66.00||$595,716.00||36,070|| |
|2/23/2016||Leanne M. Zumwalt||VP||Sell||14,587||$64.25||$937,214.75|| |
|2/16/2016||Dennis Kogod||CEO||Sell||33,290||$61.99||$2,063,647.10||120,816|| |
|1/13/2016||Christopher James Schnarr||Insider||Buy||5,000||$0.68||$3,400.00|
|1/11/2016||Christopher James Schnarr||Insider||Buy||10,000||$0.60||$6,000.00|
|12/17/2015||Laura Mildenberger||insider||Sell||1,440||$68.14||$98,121.60||8,447|| |
|9/22/2015||Kim M. Rivera||insider||Sell||40,037||$75.48||$3,021,992.76||7,438|| |
|8/17/2015||Carol Anthony Davidson||Director||Sell||4,038||$79.93||$322,757.34|| |
|6/4/2015||Robert J Margolis||Chairman||Sell||31,400||$83.39||$2,618,446.00|| |
|5/28/2015||Michael David Staffieri||COO||Sell||9,050||$84.07||$760,833.50|| |
|5/19/2015||Robert J Margolis||Chairman||Sell||15,700||$83.22||$1,306,554.00|| |
|5/18/2015||James K Hilger||CFO||Sell||3,983||$82.10||$327,004.30|| |
|5/18/2015||Michael David Staffieri||COO||Sell||2,047||$82.03||$167,915.41|| |
|5/18/2015||Robert J Margolis||Chairman||Sell||15,700||$82.24||$1,291,168.00|| |
|5/11/2015||James K Hilger||CFO||Sell||8,267||$82.00||$677,894.00|| |
|5/11/2015||Jeanine Marie Jiganti||Insider||Sell||2,481||$81.95||$203,317.95|| |
|5/11/2015||John M Nehra||Director||Sell||12,278||$81.85||$1,004,954.30|| |
|4/21/2015||Robert J Margolis||Chairman||Sell||31,400||$82.40||$2,587,360.00|| |
|4/7/2015||Robert J Margolis||Chairman||Sell||15,700||$82.15||$1,289,755.00|| |
|4/6/2015||Robert J Margolis||Chairman||Sell||15,700||$81.49||$1,279,393.00|| |
|3/27/2015||Robert J Margolis||Chairman||Sell||31,400||$81.18||$2,549,052.00|| |
|3/12/2015||Robert J Margolis||Chairman||Sell||107,374||$79.24||$8,508,315.76|| |
|2/27/2015||Robert J Margolis||Chairman||Sell||21,000||$74.29||$1,560,090.00|| |
|2/19/2015||Robert J Margolis||Chairman||Sell||21,000||$73.12||$1,535,520.00|| |
|1/30/2015||Robert J Margolis||Chairman||Sell||31,400||$75.48||$2,370,072.00|| |
|1/23/2015||Michael David Staffieri||COO||Sell||21,869||$76.05||$1,663,137.45|| |
|1/16/2015||Robert J Margolis||Chairman||Sell||31,400||$74.92||$2,352,488.00|| |
|1/8/2015||Kim M Rivera||Insider||Sell||1,111||$75.10||$83,436.10|| |
|12/30/2014||Robert J Margolis||Chairman||Sell||31,400||$76.09||$2,389,226.00|| |
|12/29/2014||Robert J Margolis||Chairman||Sell||15,700||$76.09||$1,194,613.00|| |
|12/19/2014||Laura Mildenberger||Insider||Sell||1,446||$75.50||$109,173.00|| |
|12/18/2014||Robert J Margolis||Chairman||Sell||31,400||$74.67||$2,344,638.00|| |
|12/3/2014||Robert J Margolis||Chairman||Sell||31,400||$75.80||$2,380,120.00|| |
|12/1/2014||Kim M Rivera||Insider||Sell||6,503||$76.08||$494,748.24|| |
|11/21/2014||Robert J Margolis||Chairman||Sell||31,400||$75.08||$2,357,512.00|| |
|11/11/2014||Kent J Thiry||CEO||Sell||344,938||$74.52||$25,704,779.76|| |
|11/11/2014||Robert J Margolis||Chairman||Sell||250,000||$75.09||$18,772,500.00|| |
|11/10/2014||Berkshire Hathaway Inc||Major Shareholder||Buy||944,418||$74.11||$69,990,817.98|| |
|11/7/2014||R. Ted Weschler||Major Shareholder||Buy||820,018||$74.10||$60,763,333.80|| |
|11/3/2014||Roger Valine||Director||Sell||7,185||$77.85||$559,352.25|| |
|9/16/2014||John M Nehra||Director||Sell||20,000||$73.91||$1,478,200.00|| |
|9/8/2014||Kim M Rivera||Insider||Sell||1,111||$74.25||$82,491.75|| |
|8/27/2014||Leanne M Zumwalt||VP||Sell||3,214||$74.57||$239,667.98|| |
|8/11/2014||Jeanine Marie Jiganti||Insider||Sell||2,500||$72.14||$180,350.00|| |
|6/11/2014||Kim M Rivera||Insider||Sell||5,929||$71.05||$421,255.45|| |
|5/29/2014||Laura Mildenberger||Insider||Sell||5,080||$69.99||$355,549.20|| |
|5/16/2014||Dennis Kogod||COO||Sell||18,750||$67.30||$1,261,875.00||40,874|| |
|5/16/2014||Kent Thiry||CEO||Sell||17,600||$67.41||$1,186,416.00||247,950|| |
|5/15/2014||James Hilger||CAO||Sell||1,666||$67.23||$112,005.18||13,277|| |
|5/15/2014||Javier Rodriguez||CEO||Sell||7,000||$67.50||$472,500.00||64,264|| |
|5/12/2014||Dennis Kogod||COO||Sell||32,188||$68.06||$2,190,715.28||59,624|| |
|5/8/2014||Dennis Kogod||COO||Sell||32,213||$67.36||$2,169,867.68||59,624|| |
|5/7/2014||Michael David Staffieri||COO||Sell||2,633||$67.30||$177,200.90|| |
|4/2/2014||Michael David Staffieri||COO||Sell||2,867||$69.15||$198,253.05||2,633|| |
|3/20/2014||Laura Mildenberger||Insider||Sell||3,274||$70.04||$229,310.96||6,036|| |
|2/26/2014||R. Ted Weschler||major shareholder||Buy||1,159,858||$66.97||$77,675,690.26||2,191,806|| |
|2/21/2014||John Nehra||Director||Sell||40,000||$65.81||$2,632,400.00||81,766|| |
|2/18/2014||William Roper||Director||Sell||42,519||$66.37||$2,821,986.03||4,994|| |
|12/20/2013||Laura Mildenberger||Insider||Sell||10,417||$62.53||$651,375.01||6,036|| |
|12/17/2013||Allen Nissenson||Insider||Sell||2,929||$59.83||$175,242.07||2,508|| |
|12/9/2013||Berkshire Hathaway Inc||major shareholder||Buy||1,314,170||$57.84||$76,011,592.80|| |
|11/8/2013||R. Ted Weschler||major shareholder||Buy||3,700,294||$55.14||$204,034,211.16||1,095,903|| |
|7/5/2013||Berkshire Hathaway Inc||Major Shareholder||Buy||110,309||$114.01||$12,576,329.09|| |
|7/3/2013||R. Ted Weschler||Major Shareholder||Buy||639,200||$114.78||$73,367,376.00|| |
|5/15/2013||David T Shapiro||Insider||Sell||8,779||$129.80||$1,139,514.20|| |
|5/15/2013||Dennis Kogod||COO||Sell||21,130||$129.47||$2,735,701.10|| |
|5/15/2013||James K Hilger||CFO||Sell||1,049||$130.18||$136,558.82|| |
|5/15/2013||Leanne M Zumwalt||VP||Sell||13,209||$129.59||$1,711,754.31|| |
|5/13/2013||Kent J Thiry||CEO||Sell||243,307||$129.95||$31,617,744.65|| |
|5/13/2013||Kim M Rivera||Insider||Sell||1,672||$129.70||$216,858.40|| |
|3/4/2013||Berkshire Hathaway Inc||Major Shareholder||Buy||164,947||$119.59||$19,726,011.73|| |
|3/4/2013||Roger Valine||Director||Sell||1,390||$120.00||$166,800.00|| |
|2/27/2013||Berkshire Hathaway Inc||Major Shareholder||Buy||211,889||$116.56||$24,697,781.84|| |
|2/22/2013||Berkshire Hathaway Inc||Major Shareholder||Buy||224,091||$115.88||$25,967,665.08|| |
|2/19/2013||Berkshire Hathaway Inc||Major Shareholder||Buy||323,070||$116.73||$37,711,961.10|| |
|2/5/2013||Berkshire Hathaway Inc||Major Shareholder||Buy||32,376||$115.17||$3,728,743.92|| |
|2/4/2013||Roger Valine||Director||Sell||1,389||$116.13||$161,304.57|| |
|1/16/2013||Berkshire Hathaway Inc||Major Shareholder||Buy||42,400||$111.33||$4,720,392.00|| |
|1/15/2013||Berkshire Hathaway Inc||Major Shareholder||Buy||179,300||$109.67||$19,663,831.00|| |
|1/10/2013||Berkshire Hathaway Inc||Major Shareholder||Buy||187,898||$109.54||$20,582,346.92|| |
|12/24/2012||Dennis Kogod||COO||Sell||12,736||$111.00||$1,413,696.00|| |
|12/21/2012||James K Hilger||CFO||Sell||2,073||$112.20||$232,590.60|| |
|12/6/2012||Berkshire Hathaway Inc||Major Shareholder||Buy||635,633||$106.20||$67,504,224.60|| |
|11/29/2012||Berkshire Hathaway Inc||Major Shareholder||Buy||679,249||$108.20||$73,494,741.80|| |
|11/26/2012||Berkshire Hathaway Inc||Major Shareholder||Buy||412,050||$110.38||$45,482,079.00|| |
|11/16/2012||Berkshire Hathaway Inc||Major Shareholder||Buy||132,958||$112.45||$14,951,127.10|| |
|11/12/2012||Berkshire Hathaway Inc||Major Shareholder||Buy||548,823||$112.15||$61,550,499.45|| |
|11/7/2012||Berkshire Hathaway Inc||Major Shareholder||Buy||139,491||$112.03||$15,627,176.73|| |
|11/2/2012||Berkshire Hathaway Inc||Major Shareholder||Buy||254,750||$112.20||$28,582,950.00|| |
|10/26/2012||Berkshire Hathaway Inc||Major Shareholder||Buy||257,941||$111.14||$28,667,562.74|| |
|10/17/2012||Berkshire Hathaway Inc||Major Shareholder||Buy||63,928||$109.56||$7,003,951.68|| |
|10/12/2012||Berkshire Hathaway Inc||Major Shareholder||Buy||217,597||$109.76||$23,883,446.72|| |
|10/9/2012||Berkshire Hathaway Inc||Major Shareholder||Buy||67,946||$107.71||$7,318,463.66|| |
|9/28/2012||Berkshire Hathaway Inc||Major Shareholder||Buy||282,403||$102.03||$28,813,578.09|| |
|8/8/2012||Kent J Thiry||Chairman||Sell||320,877||$96.88||$31,086,563.76|| |
|8/7/2012||William L Roper||Director||Sell||23,019||$95.95||$2,208,673.05|| |
DaVita (NYSE DVA) News Headlines
DaVita (NYSE:DVA) SEC Filings
This page is loading this company's SEC Filings. Please wait...
DaVita (NYSE:DVA) Income Statement, Balance Sheet and Cash Flow Statement
DaVita (NYSE DVA) Stock Chart for Tuesday, May, 22, 2018